Everolimus plus endocrine therapy for postmenopausal women with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a clinical trial

Nom du journal : JAMA Oncol

Année : 2018

Volume : 4

Page de départ : 977

Page de fin : 984

Auteurs: Villanueva C, Cardoso F, Bachelot T, Debled M, Royce M, Ozguroglu M, Azevedo SJ, Cruz FM, Hegg R, Toyama T, Falkson C, Jeong J, Srimuninnimit V, Gradishar WJ, Arce C, Ridolfi A, Lin C,